[Bone changes in primary hyperparathyroidism].
Fujiyama
Kaoru
K
First Department of Physiology, Nagasaki University School of Medicine.
D000814:Aniline Compounds / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D006801:Humans; D006961:Hyperparathyroidism / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016105:Parathyroidectomy; D010627:Phenethylamines; D011379:Prognosis; D011437:Propylamines
D000814:Aniline Compounds; D004164:Diphosphonates; C107873:N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine; D010627:Phenethylamines; D011437:Propylamines